Does CABERGOLINE Cause Pulmonary hypertension? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Pulmonary hypertension have been filed in association with CABERGOLINE (Cabergoline). This represents 0.9% of all adverse event reports for CABERGOLINE.
18
Reports of Pulmonary hypertension with CABERGOLINE
0.9%
of all CABERGOLINE reports
5
Deaths
10
Hospitalizations
How Dangerous Is Pulmonary hypertension From CABERGOLINE?
Of the 18 reports, 5 (27.8%) resulted in death, 10 (55.6%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABERGOLINE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does CABERGOLINE Cause?
Drug ineffective (249)
Headache (142)
Off label use (129)
Nausea (103)
Maternal exposure during pregnancy (100)
Dizziness (94)
Cerebrospinal fluid leakage (78)
Fatigue (71)
Malaise (64)
Condition aggravated (61)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which CABERGOLINE Alternatives Have Lower Pulmonary hypertension Risk?
CABERGOLINE vs CABOTEGRAVIR
CABERGOLINE vs CABOTEGRAVIR\RILPIVIRINE
CABERGOLINE vs CABOZANTINIB
CABERGOLINE vs CABOZANTINIB S-MALATE
CABERGOLINE vs CAFFEINE